I agree No excuses But I’ve seen no marketing of cyberbiz And There’s been no updates about cyberbiz from management It’s time to see some investment in this product turn into some decent returns
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come